Angion Biomedica (NASDAQ: ANGN)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Angion Biomedica (NASDAQ: ANGN) through any online brokerage.
There are no as such competitors for Angion Biomedica.
The latest price target for Angion Biomedica (NASDAQ: ANGN) was reported by HC Wainwright & Co. on Monday, July 18, 2022. The analyst firm set a price target for 0.00 expecting ANGN to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.
The stock price for Angion Biomedica (NASDAQ: ANGN) is $1.02 last updated Today at August 15, 2022, 3:55 PM UTC.
There are no upcoming dividends for Angion Biomedica.
Angion Biomedica’s Q3 earnings are confirmed for Friday, November 11, 2022.
There is no upcoming split for Angion Biomedica.
Angion Biomedica is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.